Showing results (2371-2380 of 3,090) with videos related to
Sort By:
Pageof 309
Archivos De Cardiologia De Mexico|April 22, 2021
Medical and nutritional implications in chronic heart failure: strengths and limitationsLucero Rico-de la Rosa, Miguel Robledo-Valdez, Enrique Cervantes-Pérez, et al.International Journal for Parasitology. Drugs and Drug Resistance|August 1, 2020
Mode of action of a formulation containing hydrazones and saponins against leishmania spp. Role in mitochondria, proteases and reinfection processYulieth A Upegui Zapata, Fernando Echeverri, Winston Quiñones, et al.The Lancet. Healthy Longevity|September 8, 2024
Association between surgical admissions, cognition, and neurodegeneration in older people: a population-based study from the UK BiobankJennifer Taylor, Kristy P Robledo, Vicente Medel, et al.Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.Antioxidants (Basel, Switzerland)|October 27, 2022
Vitamin E Lipid-Based Nanodevices as a Tool for Ovine Sperm Protection against Oxidative Stress: Impact on Sperm MotilityAlejandro Jurado-Campos, Pedro Javier Soria-Meneses, María Arenas-Moreira, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 3, 2014
Low doses of ochratoxin A induce micronucleus formation and delay DNA repair in human lymphocytesCyndia A González-Arias, Alma B Benitez-Trinidad, Monserrat Sordo, et al.RSC Advances|May 6, 2022
Film based on magnesium impregnated biochar/cellulose acetate for phosphorus adsorption from aqueous solutionMarina de Carvalho Eufrásio Pinto, Demetrius David da Silva, Ana Luiza Amorim Gomes, et al.Journal of Medicinal Chemistry|August 6, 2004
Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitorsBin Shao, Sam Victory, Victor I Ilyin, et al.Human Mutation|February 22, 2007
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patientsAlberto Cascón, Beatriz Escobar, Cristina Montero-Conde, et al.Pageof 309